Lyon Joseph Douglas

SEC source: 0000950170-23-052700 · ownership.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,167

Underlying: Common Stock · 2,582 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

SEC source: 0000950170-23-052700 · ownership.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,854

F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-052700 · ownership.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-051911 · ownership.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,418

Underlying: Common Stock · 2,418 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully exercisable.

SEC source: 0000950170-23-051911 · ownership.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,854

F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $27.24 to $27.28. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-051911 · ownership.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,272

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-046814 · ownership.xml · derivative · entry 5

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,167

Underlying: Common Stock · 5,000 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully exercisable.

SEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 4

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,854

F5 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,493

F3 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023.

F4 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,132

F2 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-043973 · ownership.xml · derivative · entry 5

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,167

Underlying: Common Stock · 833 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

SEC source: 0000950170-23-043973 · ownership.xml · derivative · entry 4

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,755 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

SEC source: 0000950170-23-043973 · ownership.xml · nonDerivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,132

F2 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-043973 · ownership.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-043973 · ownership.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,887

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-040748 · ownership.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,571

Underlying: Common Stock · 412 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully exercisable.

SEC source: 0000950170-23-040748 · ownership.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000950170-23-040748 · ownership.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,720

F1 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $31.21 to $31.25. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000899243-23-014751 · doc4.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,571

Underlying: Common Stock · 10,000 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully exercisable.

SEC source: 0000899243-23-014751 · doc4.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,132

F1 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.60 to $23.61. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000899243-23-014751 · doc4.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000899243-23-014515 · doc4.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,132

F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000899243-23-014515 · doc4.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,721

F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on June 1, 2023.

F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

F3 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC source: 0000899243-23-007049 · doc4.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,310

F3 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

SEC source: 0000899243-23-007049 · doc4.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,155

F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on March 1, 2023.

F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

SEC source: 0000899243-23-005177 · doc4.xml · derivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2033-02-12

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of February 13, 2023 over a four-year period.

SEC source: 0000899243-22-005961 · doc4.xml · derivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-02-01

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 2, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on February 2, 2026.

SEC source: 0000899243-21-014861 · doc4.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 25,000 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F3 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023.

SEC source: 0000899243-21-014861 · doc4.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.79 to $24.13 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

SEC source: 0000899243-21-014861 · doc4.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

SEC source: 0000899243-21-009450 · doc4.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,167

Underlying: Common Stock · 25,000 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F3 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 10, 2017, so that the total number of shares subject to this option became fully vested and exercisable on February 10, 2021.

SEC source: 0000899243-21-009450 · doc4.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $25.15 to $25.34 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

SEC source: 0000899243-21-009450 · doc4.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

SEC source: 0000899243-21-005182 · doc4.xml · derivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-02-04

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 5, 2021, so that the total number of shares subject to this option becomes fully vested and exercisable on February 5, 2025.

SEC source: 0000899243-21-004968 · doc4.xml · derivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,167

Underlying: Common Stock · 25,000 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F3 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2017, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2021.

SEC source: 0000899243-21-004968 · doc4.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.86 to $29.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

SEC source: 0000899243-21-004968 · doc4.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

SEC source: 0000899243-21-000214 · doc4.xml · derivative · entry 8

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,167

Underlying: Common Stock · 25,000 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F5 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2017, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2021.

SEC source: 0000899243-21-000214 · doc4.xml · nonDerivative · entry 5

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.05 to $26.335 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

SEC source: 0000899243-21-000214 · doc4.xml · nonDerivative · entry 4

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

SEC source: 0000899243-21-000214 · doc4.xml · derivative · entry 7

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,167

Underlying: Common Stock · 20,833 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F5 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2017, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2021.

SEC source: 0000899243-21-000214 · doc4.xml · derivative · entry 6

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,167 shares

Expires 2026-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F4 · derivative.exercise_date: Fully exercisable.

SEC source: 0000899243-21-000214 · doc4.xml · nonDerivative · entry 3

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.05 to $26.24 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

SEC source: 0000899243-21-000214 · doc4.xml · nonDerivative · entry 2

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

SEC source: 0000899243-21-000214 · doc4.xml · nonDerivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

SEC source: 0000899243-20-019199 · doc4.xml · derivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-07-13

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of July 1, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on July 1, 2024.